RexMedical- Option* Vena Cava Filter IDE Study

Completed · Not applicable

Conditions studied: Pulmonary Embolism

In brief

This study is designed to evaluate the safety and efficacy of the RexMedical Option\* Vena Cava Filter in the treatment of patients who are at increased risk for Pulmonary Embolism and require caval interruption.

Key facts

Study ID

NCT00488865

Run by

Rex Medical

People needed

100

Starts

2006-10-01

Expected to finish

2009-06-01

Last updated by the study team

2010-08-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Peninsula Surgical Specialists Medical Group, Inc. — Burlingame, California, United States
• Christiana Care Health System — Newark, Delaware, United States
• George Washington University — Washington D.C., District of Columbia, United States
• Miami Cardiac & Vascular Institute — Miami, Florida, United States
• Northwestern Memorial Hospital — Chicago, Illinois, United States
• Indiana University School of Medicine — Indianapolis, Indiana, United States
• Brigham and Women's Hospital — Boston, Massachusetts, United States
• New York Presbyterian Hospital/Columbia — New York, New York, United States
• OHSU — Portland, Oregon, United States
• University of Texas Southwestern Medical Center — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.